Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series

Author: Rodrigues M. J.   Peron J.   Frnel J.-S.   Vano Y.-A.   Wassermann J.   Debled M.   Picaud F.   Albiges L.   Vincent-Salomon A.   Cottu P. H.  

Publisher: Oxford University Press

ISSN: 0923-7534

Source: Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 916-924

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content